The AstraZeneca vaccine offers more benefits than risks that continue to occur sporadically so far.Jakarta (ANTARA) - The AstraZeneca vaccine tends to have greater benefits than risks, according to an official from the Indonesian Institute of Science (LIPI), here, Friday.
“The AstraZeneca vaccine offers more benefits than risks that continue to occur sporadically so far,” Chief of LIPI’s Laboratory for Applied Genetic Engineering and Protein Design, Wien Kusharyoto, stated.
Kusharyoto pointed out that the vaccination program implemented by using the AstraZeneca vaccine can be continued to prevent the looming risks of COVID-19, right from infection until death.
“Based on the earlier clinical tests on AstraZeneca and the uses of it this far, this vaccine is safe,” she revealed.
Several European nations, including Germany, Italy, and France, have reportedly halted the use of the AstraZeneca vaccine by this week following growing concerns over its security despite the WHO’s statement on Wednesday (Mar 17) that it has more benefits than risks.
Use of the AstraZeneca vaccine was temporarily suspended, as one of the receivers reportedly suffered from blood clots after being administered that vaccine.
Until March 10, 2021, as many as 30 blood clot cases were reported among five million people administered the AstraZeneca vaccine across the European Economic Area.
In handling such cases, Wien affirmed that these countries had adopted the prudent principle that enabled them to temporarily suspend the AstraZeneca vaccination until a direct link was established between death and the use of the vaccine. Related news: Ministry upbeat 1.1 mln AstraZeneca vaccine doses administered in May
Related news: Indonesia gets over 1 mln AstraZeneca shots under COVAX scheme
EDITED BY INE
Translator: Juwita Trisna Rahayu, Martha S
Editor: Suharto
Copyright © ANTARA 2021
